- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.06. | Anteris Technologies Global Corp.: Anteris Appoints David Roberts and Gregory Moss to its Board of Directors | 1 | GlobeNewswire (USA) | ||
| 09.06. | Anteris Technologies ernennt neue Vorstandsmitglieder und gibt Rücktritt bekannt | 2 | Investing.com Deutsch | ||
| 09.06. | Anteris Technologies Global Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| ANTERIS TECHNOLOGIES GLOBAL Aktie jetzt für 0€ handeln | |||||
| 13.05. | Anteris Technologies Global Corp.: Anteris Announces Results for the First Quarter of 2025 | 211 | GlobeNewswire (Europe) | MINNEAPOLIS and BRISBANE, Australia, May 13, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed... ► Artikel lesen | |
| 13.05. | Anteris Technologies Global Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.04. | Anteris Technologies Global Corp. - 10-K/A, Annual Report | - | SEC Filings | ||
| 31.03. | Anteris meldet über 100 Patienten, die mit neuer Herzklappe behandelt wurden | 2 | Investing.com Deutsch | ||
| 31.03. | Anteris reports over 100 patients treated with new heart valve | 1 | Investing.com | ||
| 31.03. | Anteris Technologies Global Corp.: Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV | 237 | GlobeNewswire (Europe) | MINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed... ► Artikel lesen | |
| 31.03. | Anteris Technologies Global Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.03. | Elutia stock soars, Anteris falls in medical devices sector | 4 | Investing.com | ||
| 13.03. | Anteris Technologies Global Corp. reports FY results | 1 | Seeking Alpha | ||
| 13.03. | Anteris Technologies Global Corp.: Anteris Reports 2024 Financial Results and Provides Corporate Update | 283 | GlobeNewswire (Europe) | EAGAN, Minn. and BRISBANE, Australia, March 12, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed... ► Artikel lesen | |
| 12.03. | Anteris Technologies Global Corp. - 10-K, Annual Report | 2 | SEC Filings | ||
| 06.03. | Anteris Technologies Global Corp. - 8-K, Current Report | - | SEC Filings | ||
| 15.01. | Anteris Technologies Global Corp. - 8-K, Current Report | - | SEC Filings | ||
| 13.12.24 | Anteris Technologies Prices 14.80 Mln Shares IPO At $6/shr | 738 | AFX News | CANBERA (dpa-AFX) - Anteris Technologies Global Corp. or ATGC, an Australian structural heart company, announced Friday that it has priced its initial public offering of 14.80 million shares... ► Artikel lesen | |
| 13.12.24 | Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering | 211 | Business Wire | BRISBANE, Australia & EAGAN, Minn.--(BUSINESS WIRE)--Anteris Technologies Global Corp. ("ATGC") today announced the pricing of its initial public offering of 14,800,000 shares of its common stock... ► Artikel lesen | |
| 09.12.24 | Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering | 205 | Business Wire | BRISBANE, Australia & EAGAN, Minn.--(BUSINESS WIRE)--Anteris Technologies Global Corp. ("ATGC") today announced that it has launched the roadshow for its proposed initial public offering of 14... ► Artikel lesen | |
| 25.11.24 | Anteris Technologies Global Corp. Files Registration Statement For U.S. IPO | 568 | AFX News | WASHINGTON (dpa-AFX) - Anteris Technologies Global Corp. announced that it has filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission, relating to the proposed... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| FAMICORD | 4,220 | 0,00 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG 06.06.2025 / 17:08 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung... ► Artikel lesen | |
| GERATHERM MEDICAL | 3,390 | +2,11 % | Geratherm Medical AG: GJ24 war herausfordernd, vorsichtige Prognose für GJ25; mwb research bekräftigt KAUFEN | Die Ergebnisse von Geratherm für das Geschäftsjahr 2024 zeigten einen Umsatzrückgang von 33% auf 14,0?Mio.?EUR, was in erster Linie auf deutliche Rückgänge in den Bereichen Healthcare Diagnostics und... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,365 | 0,00 % | Plus Therapeutics Expects Meaningful Revenue Contributions From CNSide Diagnostics In 2026 | WASHINGTON (dpa-AFX) - Plus Therapeutics, Inc. (PSTV), a clinical-stage pharmaceutical company, expects the revenue contributions of CNSide Diagnostics, LLC to 'become meaningful' in fiscal... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,704 | -5,38 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| MEDICLIN | 3,060 | 0,00 % | EQS-News: MEDICLIN AG: Ordentliche Hauptversammlung stimmt allen Beschlussvorschlägen zu | EQS-News: MEDICLIN AG
/ Schlagwort(e): Hauptversammlung
MEDICLIN AG: Ordentliche Hauptversammlung stimmt allen Beschlussvorschlägen zu
04.06.2025 / 13:27 CET/CEST
Für... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,946 | +9,49 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| PROGYNY | 21,460 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
| PROCEPT BIOROBOTICS | 58,63 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
| ADAPTHEALTH | 9,420 | 0,00 % | AdaptHealth Corp. - 10-K/A, Annual Report | ||
| SIEMENS HEALTHINEERS | 46,690 | -0,32 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Neutral" belassen. Die Bayern gehörten im europäischen Medtech-Bereich... ► Artikel lesen | |
| PHETON | 17,540 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
| RXSIGHT | 13,230 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
ANTERIS TECHNOLOGIES GLOBAL CORP gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 3,990 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ANTERIS TECHNOLOGIES GLOBAL CORP finden Sie auf Wallstreet Online.